Revenue, last quarter
$0
Net income
−$4.2M
+34.2% vs same quarter last year
EPS, diluted
-
Operating cash flow
−$4.3M
+30.1% vs same quarter last year
Source: SEC XBRL filings · latest filing
- Revenue
- Net income
Show the numbers
| Year | Revenue | Net income |
|---|---|---|
| FY25 | $2.5M | −$21.5M |
| FY24 | $4M | −$25M |
| FY23 | $0 | −$26M |
| FY22 | $81.5K | −$14M |
| FY21 | $385.5K | −$18.6M |
| FY20 | $1.8M | −$3M |
| FY19 | $1.2M | −$2.4M |
| FY18 | $963.2K | −$2.6M |
| FY17 | $1.1M | −$2.2M |
| FY16 | $828.9K | −$3.3M |
| FY15 | - | −$2.7M |
| FY14 | - | −$2.7M |
| FY13 | - | −$2.3M |
| FY12 | - | −$2.1M |
| FY11 | - | −$2.3M |
- Operating margin
- Net margin
Show the numbers
| Year | Operating margin | Net margin |
|---|---|---|
| FY25 | −869.3% | −862.3% |
| FY24 | −635.8% | −632% |
| FY23 | - | - |
| FY22 | −17207.5% | −17198.3% |
| FY21 | −4862.7% | −4817.2% |
| FY20 | −154.5% | −162.2% |
| FY19 | −201.8% | −201.6% |
| FY18 | −266.1% | −265.8% |
| FY17 | −202.2% | −201.8% |
| FY16 | −394.9% | −394.7% |
| FY15 | - | - |
| FY14 | - | - |
| FY13 | - | - |
| FY12 | - | - |
| FY11 | - | - |
Show the numbers
| Year | Free cash flow |
|---|---|
| FY25 | −$21.5M |
| FY24 | −$24.7M |
| FY23 | −$25.2M |
| FY22 | −$19.2M |
| FY21 | −$11.2M |
| FY20 | −$2.9M |
| FY19 | −$1.4M |
| FY18 | - |
| FY17 | −$1.7M |
| FY16 | - |
| FY15 | −$2.7M |
| FY14 | −$2.3M |
| FY13 | −$1.8M |
| FY12 | - |
| FY11 | −$315.5K |
- GeoVax Labs
- Healthcare median
Show the numbers
| Year | GeoVax Labs | Healthcare median |
|---|---|---|
| FY25 | −862.3% | −30.6% |
| FY24 | −632% | −47% |
| FY23 | - | −58% |
| FY22 | −17198.3% | −80.4% |
| FY21 | −4817.2% | −71.8% |
| FY20 | −162.2% | −62.2% |
| FY19 | −201.6% | −46.2% |
| FY18 | −265.8% | −49.6% |
| FY17 | −201.8% | −45.9% |
| FY16 | −394.7% | −36% |
| FY15 | - | −37.8% |
| FY14 | - | −35.5% |
| FY13 | - | −37.1% |
| FY12 | - | −29.1% |
| FY11 | - | −27.9% |